Search details
1.
Therapeutic Ligands Antagonize Estrogen Receptor Function by Impairing Its Mobility.
Cell
; 178(4): 949-963.e18, 2019 08 08.
Article
in English
| MEDLINE | ID: mdl-31353221
2.
Maternal help-seeking for child developmental concerns: Associations with socio-demographic factors.
J Paediatr Child Health
; 53(10): 963-969, 2017 Oct.
Article
in English
| MEDLINE | ID: mdl-28661061
3.
RTK-Dependent Inducible Degradation of Mutant PI3Kα Drives GDC-0077 (Inavolisib) Efficacy.
Cancer Discov
; 12(1): 204-219, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34544753
4.
GDC-9545 (Giredestrant): A Potent and Orally Bioavailable Selective Estrogen Receptor Antagonist and Degrader with an Exceptional Preclinical Profile for ER+ Breast Cancer.
J Med Chem
; 64(16): 11841-11856, 2021 08 26.
Article
in English
| MEDLINE | ID: mdl-34251202
5.
The PI3K inhibitor taselisib overcomes letrozole resistance in a breast cancer model expressing aromatase.
Genes Cancer
; 7(3-4): 73-85, 2016 Mar.
Article
in English
| MEDLINE | ID: mdl-27382432
6.
Antisense oligonucleotides to N-methyl-D-aspartate receptor subunits attenuate formalin-induced nociception in the rat.
Brain Res
; 930(1-2): 163-9, 2002 Mar 15.
Article
in English
| MEDLINE | ID: mdl-11879806
7.
GDC-0941, a novel class I selective PI3K inhibitor, enhances the efficacy of docetaxel in human breast cancer models by increasing cell death in vitro and in vivo.
Clin Cancer Res
; 18(14): 3901-11, 2012 Jul 15.
Article
in English
| MEDLINE | ID: mdl-22586300
8.
Active PI3K pathway causes an invasive phenotype which can be reversed or promoted by blocking the pathway at divergent nodes.
PLoS One
; 7(5): e36402, 2012.
Article
in English
| MEDLINE | ID: mdl-22570710
9.
GDC-0980 is a novel class I PI3K/mTOR kinase inhibitor with robust activity in cancer models driven by the PI3K pathway.
Mol Cancer Ther
; 10(12): 2426-36, 2011 Dec.
Article
in English
| MEDLINE | ID: mdl-21998291
10.
Nuclear phospho-Akt increase predicts synergy of PI3K inhibition and doxorubicin in breast and ovarian cancer.
Sci Transl Med
; 2(48): 48ra66, 2010 Sep 08.
Article
in English
| MEDLINE | ID: mdl-20826841
11.
Predictive biomarkers of sensitivity to the phosphatidylinositol 3' kinase inhibitor GDC-0941 in breast cancer preclinical models.
Clin Cancer Res
; 16(14): 3670-83, 2010 Jul 15.
Article
in English
| MEDLINE | ID: mdl-20453058
Results
1 -
11
de 11
1
Next >
>>